{
    "2021-04-03": [
        [
            {
                "time": "",
                "original_text": "基因测序双周榜：药明康德触底反弹“王者归来”？国际医学迎明星基金经理调研",
                "features": {
                    "keywords": [
                        "基因测序",
                        "药明康德",
                        "触底反弹",
                        "国际医学",
                        "明星基金经理",
                        "调研"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：业绩符合预期 多个产品上市在即",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "业绩",
                        "产品上市"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}